Trial Profile
ONO-6950 Phase I Study (Single-dose, oral administration)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 May 2018
Price :
$35
*
At a glance
- Drugs Gemilukast (Primary)
- Indications Asthma
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Ono Pharmaceutical
- 03 Jun 2016 New trial record